Gerhard Ruedl

Dr. Gerhard Ruedl

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2001 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
WSW Söllner
W Söllner
ADA DeVries
A DeVries
ESE Steixner
E Steixner
PLP Lukas
P Lukas
GSG Sprinzl
G Sprinzl
SMS Maislinger
S Maislinger
20–40% of cancer patients show emotional distress. Psychosocial support should be offered to severely distressed patients. However, little is known about the selection of patients to whom such support should be offered. This study investigated oncologists' ability to identify such patients. In a consecutive series of 298 cancer patients undergoing radiotherapy, distress, perceived social support and desire for supportive counselling were assessed using screening instruments. Simultaneously, 8 oncologists estimated patient distress and need for psychosocial support. A complete set of data was obtained in 80.2% of cases. Concordance of the oncologists' estimation of patient distress and perceived social support with the results of the screening instruments was weak (κ=0.10 and κ=0.05). Oncologists recognized the presence of severe distress only in 11 of the 30 severely distressed patients. Correct perception of distress was lower in patients with head and neck cancer and lung cancer and in lower class patients. Oncologists' recommendations for supportive counselling did not correlate with patient distress or the amount of perceived support but rather with progressive disease and less denial behaviour. Our results underline the need for educating oncologists in order to improve their ability to identify patient distress. © 2001 Cancer Research Campaign http://www.bjcancer.com

28 July 2010 in The Oncologist
Verified
Journal Article
Open access
PDF file
AZAugust Zabernigg
August Zabernigg
EGEva-Maria Gamper
Eva-Maria Gamper
JGJohannes M. Giesinger
Johannes M. Giesinger
Gerhard RuedlGerhard Ruedl
Gerhard Ruedl
GKGeorg Kemmler
Georg Kemmler
BHBernhard Holzner
Bernhard Holzner
Learning Objectives: After completing this course, the reader will be able to: Evaluate the effect of various chemotherapy regimens on taste alterations.Investigate the effect of chemotherapy-induced taste alterations on patients and use available dietary approaches such as taste enhancement and substitution of proteins and nutrients of avoided food to improve quality of life. CME This article is available for continuing medical education credit at CME.TheOncologist.com. Background.: Taste alterations (TAs) are a frequent but under-recognized treatment side effect in cancer patients undergoing chemotherapy (CT). CT regimens with different toxicity profiles may vary in their impact on TAs, but research on this topic is lacking. This study assesses the prevalence of TAs and their relation to sociodemographic and clinical variables, especially CT regimens. Furthermore, the association between TAs and quality of life (QOL) is investigated. Patients and Methods.: TAs and QOL data were collected longitudinally in 197 cancer patients (lung cancer, 54.3%; pancreatic cancer, 19.3%; colorectal cancer, 26.4%; age, 65.2 ±10.4 years; male, 57.4%) who were receiving CT at the Department of Internal Medicine at Kufstein County Hospital, giving rise to a total of 1,024 assessment times. Patients completed the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire and two additional questions taken from the EORTC item bank concerning TAs. Statistical analyses were performed using mixed-effect models. Results.: The study showed that the prevalence of TAs in chemotherapy patients is alarmingly high (69.9%). There were clear differences in TA scores among treatment groups: patients receiving irinotecan reported significantly more TAs than patients in other treatment groups; patients receiving a combination of gemcitabine and a platinum agent reported the lowest TAs. Additionally, significant associations between TAs and several QOL dimensions were found, especially with appetite loss and fatigue. Conclusion.: The high prevalence of TAs and their impact on QOL in CT patients underscore the urgent need for increased attention to this side effect, both in research and in clinical practice.

9 November 2012 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
BHBernhard Holzner
Bernhard Holzner
JGJohannes M Giesinger
Johannes M Giesinger
JPJakob Pinggera
Jakob Pinggera
SZStefan Zugal
Stefan Zugal
FSFelix Schöpf
Felix Schöpf
Gerhard RuedlGerhard Ruedl
Gerhard Ruedl
Patient-reported Outcomes (PROs) capturing e.g., quality of life, fatigue, depression, medication side-effects or disease symptoms, have become important outcome parameters in medical research and daily clinical practice. Electronic PRO data capture (ePRO) with software packages to administer questionnaires, storing data, and presenting results has facilitated PRO assessment in hospital settings. Compared to conventional paper-pencil versions of PRO instruments, ePRO is more economical with regard to staff resources and time, and allows immediate presentation of results to the medical staff.

15 August 2000 in Cancer
Verified
Journal Article
Closed access
PDF file
WSWolfgang Söllner
Wolfgang Söllner
SMSusanne Maislinger
Susanne Maislinger
ADAlexander DeVries
Alexander DeVries
ESEva Steixner
Eva Steixner
Gerhard RuedlGerhard Ruedl
Gerhard Ruedl
PLPeter Lukas
Peter Lukas

1 April 2003 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
ALAstrid Lampe
Astrid Lampe
SDStephan Doering
Stephan Doering
Gerhard RuedlGerhard Ruedl
Gerhard Ruedl
ESElisabeth Sölder
Elisabeth Sölder
MKMartin Krismer
Martin Krismer
WSWolfgang Söllner
Wolfgang Söllner

1 May 2000 in Psychosomatic Medicine
Verified
Journal Article
Closed access
SDStephan Doering
Stephan Doering
FKFlorian Katzlberger
Florian Katzlberger
Gerhard RuedlGerhard Ruedl
Gerhard Ruedl
SRSilvia Roessler
Silvia Roessler
BHBeatrix Hofstoetter
Beatrix Hofstoetter
GSGerhard Schuessler
Gerhard Schuessler
Elective surgery represents a considerable source of stress for the patient. Many attempts have been made to prepare patients before surgery with the aim of reducing stress and improving outcome. This study used a novel approach to fulfill this aim by showing a videotape of a patient undergoing total hip replacement surgery, covering the time period from hospital admission to discharge, that strictly keeps to the patient’s perspective. Before elective total hip replacement surgery, 100 patients were randomly assigned to a control group or a preparation group; the latter group was shown the videotape on the evening before surgery. Anxiety and pain were evaluated daily for 5 days, beginning with the preoperative day, by means of the State-Trait Anxiety Inventory and a visual analog scale. Intraoperative heart rate and blood pressure, as well as postoperative intake of analgesics and sedatives, were recorded. Urinary levels of cortisol, epinephrine, and norepinephrine were determined in 12-hour samples collected at night for 5 nights, beginning with the preoperative night. Compared with the control group, the preparation group showed significantly less anxiety on the morning before surgery and the mornings of the first 2 postoperative days, and significantly fewer of them had an intraoperative systolic blood pressure increase of more than 15%. The pain ratings did not differ significantly between the two groups, but the prepared patients needed less analgesic medication after surgery. Prepared patients had significantly lower cortisol excretion during the preoperative night and the first 2 postoperative nights. Excretion of catecholamines did not differ significantly between groups. We conclude that use of the videotape decreased anxiety and stress, measured in terms of urinary cortisol excretion and intraoperative systolic blood pressure increase, in patients undergoing hip replacement surgery and prepared them to cope better with postoperative pain.